Outcomes of robotic liver resections for colorectal liver metastases. A multi-institutional analysis of minimally invasive ultrasound-guided robotic surgery.
Adult
Aged
Aged, 80 and over
Colorectal Neoplasms
/ diagnostic imaging
Female
Follow-Up Studies
Hepatectomy
/ mortality
Humans
Liver Neoplasms
/ diagnostic imaging
Male
Middle Aged
Minimally Invasive Surgical Procedures
/ mortality
Postoperative Complications
Prognosis
Retrospective Studies
Robotic Surgical Procedures
/ mortality
Surgery, Computer-Assisted
/ methods
Survival Rate
Ultrasonography
/ methods
Colorectal liver metastasis
Hepatectomy
Liver surgery
Minimally invasive liver surgery
Robotic liver surgery
Journal
Surgical oncology
ISSN: 1879-3320
Titre abrégé: Surg Oncol
Pays: Netherlands
ID NLM: 9208188
Informations de publication
Date de publication:
Mar 2019
Mar 2019
Historique:
received:
28
08
2018
revised:
18
10
2018
accepted:
30
10
2018
entrez:
11
3
2019
pubmed:
11
3
2019
medline:
10
7
2019
Statut:
ppublish
Résumé
Current evidence supporting robotics to perform minimally invasive liver resection is based on single center case series reporting surgical outcomes in heterogeneous groups of patients. On the contrary, relatively scarce data specifically focusing on secondary hepatic malignancies is available. The objective of this study is to assess short- and long-term outcomes following liver resection for colorectal liver metastasis on a multi-institutional series of patients. All consecutive patients undergoing robotic surgery for colorectal liver metastasis at three different tertiary hospitals over a 10-year time frame were included in this analysis. All patients received ultrasound-guided liver resection according to tumor location following the principle of parenchymal sparing surgery. Perioperative, clinicopathologic and oncological outcomes were assessed. A total of 59 patients underwent liver resection. There were 7 cases of conversion to open surgery. The postoperative complication rate was 27%, 5% being the rate of major morbidity. Overall, the mean postoperative hospital stay was 6 days and no mortality occurred. R0 resection was achieved for 92% of lesions. At a mean follow-up of 19 months, the 1-year and 3-year DFS was 83.5% and 41.9%, while the 1-year and 3-year OS was 90.4% and 66.1%, respectively. Robotic liver surgery does not impair surgical outcome and oncological results in patients with liver metastases from colorectal cancer.
Sections du résumé
BACKGROUND
BACKGROUND
Current evidence supporting robotics to perform minimally invasive liver resection is based on single center case series reporting surgical outcomes in heterogeneous groups of patients. On the contrary, relatively scarce data specifically focusing on secondary hepatic malignancies is available. The objective of this study is to assess short- and long-term outcomes following liver resection for colorectal liver metastasis on a multi-institutional series of patients.
METHODS
METHODS
All consecutive patients undergoing robotic surgery for colorectal liver metastasis at three different tertiary hospitals over a 10-year time frame were included in this analysis. All patients received ultrasound-guided liver resection according to tumor location following the principle of parenchymal sparing surgery. Perioperative, clinicopathologic and oncological outcomes were assessed.
RESULTS
RESULTS
A total of 59 patients underwent liver resection. There were 7 cases of conversion to open surgery. The postoperative complication rate was 27%, 5% being the rate of major morbidity. Overall, the mean postoperative hospital stay was 6 days and no mortality occurred. R0 resection was achieved for 92% of lesions. At a mean follow-up of 19 months, the 1-year and 3-year DFS was 83.5% and 41.9%, while the 1-year and 3-year OS was 90.4% and 66.1%, respectively.
CONCLUSIONS
CONCLUSIONS
Robotic liver surgery does not impair surgical outcome and oncological results in patients with liver metastases from colorectal cancer.
Identifiants
pubmed: 30851888
pii: S0960-7404(18)30343-8
doi: 10.1016/j.suronc.2018.10.011
pii:
doi:
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
14-18Subventions
Organisme : NIH HHS
ID : S10 OD018164
Pays : United States
Informations de copyright
Copyright © 2018 Elsevier Ltd. All rights reserved.